Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases.
E L White, W B Parker, L J Macy, S C Shaddix, G McCaleb, J A Secrist, R Vince, W M Shannon
Index: Biochem. Biophys. Res. Commun. 161 , 393, (1989)
Full Text: HTML
Abstract
Carbocylic 2',3'-didehydro-2',3'-dideoxyguanosine (Carbovir; NSC 614846) is an antiretroviral agent which may be useful in the treatment of AIDS. We have synthesized the 5'-triphosphate of Carbovir and examined its ability to inhibit human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (EC 2.7.7.49) and other retroviral reverse transcriptases, as well as human DNA polymerases alpha, beta, gamma (EC 2.7.7.7) and DNA primase (EC 2.7.7.6). Carbovir triphosphate emerges as a highly selective inhibitor of reverse transcriptases with little, if any, effect on the cellular enzymes. 3'-Azido-2',3'-dideoxythymidine (AZT) triphosphate and the two dideoxynucleoside triphosphates, ddTTP and ddGTP, inhibited HIV-1 reverse transcriptase to the same degree as Carbovir triphosphate, but were less selective in that they also inhibited DNA polymerases beta and gamma. We conclude that Carbovir is a highly selective antiretroviral agent.
Related Compounds
Related Articles:
1990-01-01
[J. Med. Chem. 33 , 17, (1990)]
Evans, C.T. et al.
[J. Chem. Soc. Perkin Trans. I , 589, (1992)]
Campbell, J.A. et al.
[J. Org. Chem. 60 , 4602, (1995)]
Handa, S. et al.
[J. Chem. Soc. Perkin Trans. I , 1885, (1994)]
Jung. M.E. Rhee, H.
[J. Org. Chem. 59 , 4719, (1994)]